「senju pharmaceutical」の検索結果
454件：356～360件目を表示
もしかして
-
研究開発の取り組み | 千寿製薬株式会社
cal trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senju.co.jp* When contacting us by e-mail, please change "★" to "@" in the e-mai...
https://www.senju.co.jp/english/rd/ -
千寿製薬株式会社
Transient Receptor Potential cation channel subfamily V member 1 Inhibition（PDF） September 4, 2025 Senju has developed and obtained approval for a BAC-free formulation of Aibeta® combination eye drop...
http://www.senju.co.jp/english/ -
General Announcement: April 23, 2024 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for NAVIS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution ...
https://www.senju.co.jp/system/files/content_news/2024-04/ENG_20240423.pdf -
General Announcement: May 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion S...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509.pdf -
General Announcement: July 26, 2024 Senju Pharmaceutical Co., Ltd. Launch of Distribution of RET-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinaf...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726_0.pdf